Media Media Releases 2017 February 27, 2017New frontiers in cancer research and treatment to be explored by global experts at Tucson Symposium 2016 November 21, 2016Roche launches DISCOVERY 5-Plex procedure for cancer research applicationsNovember 08, 2016FDA approves Roche’s VENTANA ALK (D5F3) CDx Assay for use on the VENTANA BenchMark ULTRA systemOctober 27, 2016Roche announces FDA approval for VENTANA PD-L1 (SP142) Assay to support immunotherapy treatment decisions in lung cancermoreJuly 21, 2016Ventana Medical Systems, Inc. honored as one of Arizona’s Most Admired CompaniesMay 18, 2016Roche receives FDA Approval for novel PD-L1 biomarker assayMarch 11, 2016Roche launches new chromogen for cancer researchMarch 08, 2016Roche receives China Food and Drug Administration (CFDA) approval for the CINtec® PLUS Cytology test to help prevent women from developing cervical cancerFebruary 08, 2016Latest developments in cancer research and treatment explored by top global scientists at Tucson Symposium 2015 November 9, 2015 Roche launches new H&E tissue staining solution – the VENTANA HE 600 system June 16, 2015 Clinical value of Roche’s CINtec® PLUS Cytology test confirmed for women with abnormal cervical cytology screening results June 15, 2015 Ventana receives FDA approval for the first fully automated IHC companion diagnostic to identify lung cancer patients eligible for XALKORI® (crizotinib) more May 27, 2015 Halozyme, Ventana enter into global agreement to collaboratively develop companion daignostic for cancer treatment April 14, 2015 Ventana Medical Systems, Inc. and Astellas Pharma join forces to leverage novel companion diagnostic tests for targeted cancer treatments March 3, 2015 Global scientific collaborators to explore latest pathology and oncology advancements at Tucson Symposium January 21, 2015 Ventana seeks FDA premarket approval for ALK IHC companion diagnostic to benefit lung cancer patients 2014 October 28, 2014 Ventana announces collaboration to develop companion diagnostics for ImmunoGen’s targeted anticancer agents August 25, 2014 Spring Bioscience launches highly sensitive PDL1 (SP142) antibody for immunotherapy research August 20, 2014 Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis. more August 5, 2014 Ventana paves the way for companion diagnostic early phase clinical trials in China to advance patient care July 10, 2014 Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment June 4, 2014 Ventana Medical Systems, Inc. and MedImmune collaborate to develop a custom PD-L1 Assay for immunotherapy clinical trials May 21, 2014 Ventana Companion Diagnostics CAP/CLIA lab launches new Robust Prototype Assays May 19, 2014 Ventana launches new software platform for enhanced pathology education VMSI Media Relations. Ventana expands its portfolio of digital pathology April 3, 2014 Ventana signs companion diagnostic agreement with international biotech for antibody drug conjugate program Mar 27, 2014 Ventana supports World Health Organization’s global classification of haematopoietic and lymphoid cancers Mar 11, 2014 Ventana and Bayer Extend Collaboration Mar 5, 2014 International panel of pathology leaders develop principles for patient safety Feb 25, 2014 Ventana Medical Systems, Inc. convenes international patient safety advisory board to advance standard of care and reduce risk of misdiagnosis Feb 13, 2014 Tucson to host globally recognized cancer research conference Feb. 25 and 26 2013 Dec 13, 2013 Ventana announces HER2 companion diagnostic to identify breast cancer patients for Roche’s latest targeted medicines, Perjeta and Kadcyla Dec 5, 2013 Ventana receives FDA clearance for Estrogen Receptor (ER) Image Analysis and Digital Read Application for breast cancer Nov 26, 2013 Ventana presents CareGiver remote support at 2013 DreamForce more Nov 5, 2013 Ventana to partner with Incyte on the development of Companion Diagnostic tests Nov 4, 2013 Landmark study of more than 27,000 women shows favorable results of Roche’s CINtec PLUS cytology test October 22, 2013 Ventana launches fully automated Gram Stain on the BenchMark Special Stains platform October 4, 2013 Ventana Medical Systems, Inc. and The University of Arizona present “A Brief Overview of Prostate and Lung Cancer from Diagnosis to Treatment” October 1, 2013 Ventana launches first fully automated IHC test to detect BRAF V600E mutation in a variety of cancers September 19, 2013 Ventana to collaborate with Boehringer Ingelheim on the development of companion diagnostic tests September 11, 2013 Ventana receives approval from China’s FDA for first fully automated IHC companion diagnostic identifying ALK protein expression in lung cancer patients September 9, 2013 New test for cancer researchers targets important tumor-suppressor protein September 4, 2013 Ventana and EMC join forces to take digital pathology into the world of Big Data July 18, 2013 Journal of Histotechnology Reports on Real Risk of Errors in Tissue Biopsy Processing June 25, 2013 Ventana Medical Systems, Inc. and Translational Genomics Research Institute (TGen) join forces to fight cancer June 19, 2013 Tucson Medical Center and Ventana Medical Systems, Inc. celebrate continuous extraordinary advancements to TMC’s laboratory June 4, 2013 Uncovering cancer in today’s anatomic pathology lab VENTANA digital pathology software: finding and analyzing cancer with a click June 3, 2013 Ventana and Barco revolutionize digital pathology viewing experience May 22, 2013 23 interns to experience true value of cancer diagnostics April 25, 2013 Ventana Young Scientist’s Day gives local students hands-on experience in high-tech cancer diagnostics March 8, 2013 pr_2013-03-08_TucsonSymposium February 26, 2013 pr_2013-02-26_P63 2012 December 11, 2012 Ventana Children’s Walk raises awareness for vulnerable children in Tucson and Africa November 19, 2012 Ventana CEO Headlines Congressional Briefing on Patient Safety and Cancer. Often-overlooked patient safety risks in medical laboratories take center stage in effort to continue to improve US standards November 1, 2012 The University of Arizona and Ventana Medical Systems, Inc. present “Understanding Prostate Cancer from Diagnosis to Treatment” more October 25, 2012 Ventana launches first fully automated IHC companion diagnostic in Europe to identify ALK protein expression in lung cancer patients October 23, 2012 Ventana Scientists to reveal latest advancements in Multiplexing Gene and Protein Targets for Personalized Medicine and Breast Cancer Testing at Pathology Visions 2012 September 26, 2012 Ventana Unveils the Latest in Digital Pathology and Lab Workflow Solutions at IAP 2012 in Cape Town September 10, 2012 New CAP – ASCCP Consensus Terminology Guidelines Include Strong Recommendations for p16 Biomarker Use in the Assessment of Cervical and Other Lower Anogenital Tract Tissue September 6, 2012 Ventana Medical Systems, Inc. develops firstever fully automated dual-stain technique for miRNA and protein detection in cancer July 17, 2012 Ventana supports World Patient Safety Day June 13, 2012 Ventana takes Digital Pathology to a new level with the new VENTANA iScan HT Scanner May 31, 2012 Ventana signs exclusive licensing agreement for the commercialization of a novel BRAF V600E mutation antibody for cancer detection May 21, 2012 Ventana licenses Gen-Probe IP for measuring ERG protein in prostate cancer patients. Emerging biomarker will enable novel clinical assays and Personalized Healthcare for prostate cancer May 17, 2012 ARUP Laboratories celebrates new state-of-the-art diagnostic technology with the VENTANA BenchMark Special Stains system May 7, 2012 Ventana Receives FDA Clearance for p53 (DO-7) Image Analysis and Digital Read Applications April 20, 2012 Ventana Honored in The Congressional Record for Leadership in Patient Safety April 12, 2012 Seattle Genetics and Millennium to Collaborate with Ventana on Companion Diagnostic for ADCETRIS™ in CD30-Positive Malignancies March 26, 2012 Tucson Symposium draws over 450 scientists focused on personalized healthcare in oncology March 19, 2012 Ventana introduces the BenchMark Special Stains platform March 13, 2012 Ventana Receives FDA Clearance for Progesterone Receptor (1E2) Image Analysis and Digital Read Applications March 1, 2012 Ventana receives FDA approval of INFORM HER2 Dual ISH assay on the BenchMark ULTRA February 28, 2012 Ventana Receives FDA Clearance for Ki-67 (30-9) Image Analysis and Digital Read Applications February 20, 2012 Ventana Honored by Department of Defense for Extraordinary Support of Employees Who Serve in the Arizona National Guard and Reserve January 17, 2012 Ventana Medical Systems, Inc. to Collaborate with Bayer on Companion Diagnostic Test for new Biological Cancer Therapy — Stratifying patients for the appropriate, targeted therapy may prove to be a significant step towards personalized medicine in cancer treatment January 10, 2012 Ventana to collaborate with Pfizer and CST on companion diagnostic to identify lung cancer patients with ALK gene rearrangements 2011 December 12, 2011 Ventana Medical Systems, Inc. and Advanced Cell Diagnostics Enter Worldwide Co-Promotion Agreement for Fully Automated RNA In Situ Hybridization Assay Systems November 21, 2011 Ventana Medical Systems, Inc. appoints new Medical Director for Digital Pathology October 27, 2011 Ventana Medical Systems, Inc. introduces groundbreaking laboratory workflow integration. Virtuoso digital pathology software and the VANTAGE workflow management solution work together for improved lab management more October 24, 2011 Ventana Receives FDA Clearance for HER2 (4B5) Image Analysis and Digital Read Applications October 4, 2011 Ventana Medical Systems, Inc. Receives First FDA 510(k) Clearance for H. Pylori Antibody September 12, 2011 Early Adopter of INFORM HER2 Dual ISH Assay Optimistic about Impact on Patient Care, Hospital Bottom Line September 11, 2011 Ventana Medical Systems, Inc. Unveils High-throughput Slide Scanner for Digital Pathology August 12, 2011 Ventana Medical Systems, Inc. launches BenchMark ULTRA with new Ultimate Reagent Access (URA) for enhanced processing of IHC and ISH patient samples August 1, 2011 Roche appoints Mara G. Aspinall President of Ventana Medical Systems, Inc. July 26, 2011 Ventana Medical Systems, Inc. launches first fully automated IHC detection kit with customizable detection chemistry July 18, 2011 Roche acquires mtm laboratories AG, expanding offering in cervical cancer testing June 14, 2011 Ventana Medical Systems, Inc. receives FDA approval for the first fully automated diagnostic assay for HER2 gene status determination in breast cancer patients March 30, 2011 Ventana Medical Systems, Inc. Launches Virtuoso Software for Digital Pathology 2010 August 22, 2010 Roche acquires BioImagene, a leading provider of digital pathology laboratory solutions June 9, 2010 Precision breast panel analysis with the Ventana VIAS Image Analysis System May 6, 2010 Ventana Medical Systems, Inc. awarded first place at the 32nd Annual Diagnostic Marketing Association (DxMA)Conference and Creative Communications Awards Ventana in the Media 2016 Roche Changing Cancer Diagnostics Ventana Medical Systems Improves Cancer Diagnostics Star 200: Ventana’s companion tests drive growth Ventana Medical Systems, Inc., leaders Dr. Tom Grogan and Dr. Eric Walk share their insights into growing the biomedical industry during an interview at Tucson Symposium with Arizona Public Media University of Leeds announces sale of virtual microscope technology 2015 Ventana Medical Systems, Inc.: An Office that’s a Work of Art, Jul., 2015 2014 CLP: Navigating Pathology Risk, Patient Safety Seeks a Boost from Improved Practices in Anatomic and Digital Pathology, pp 16-20, Oct. 10, 2014 Histotechnology Takes Aim at Automation, Aug., 2014 Ventana Receives Manufacturing Excellence Award, Oct. 27, 2014 more Frost & Sullivan Applauds the Diversity of Ventana Products and Services for the Cancer Diagnostics Market, Sept 30, 2014 CLP: Histotechnology Faces New and Ongoing Challenges, pp 8-10, Aug. 12, 2014 Inside Track: Pathology and Patient Safety, CLP Online Magazine, March 25, 2014, page 36 Governor tours Oro Valley bioscience firms, Feb 12, 2014 First Ever International School of Biomedical Diagnostics Launched, Jan 7, 2014 2013 Roche pairs Ventana breast cancer test with two more of its blockbuster drugs, FierceMedical Devices, Dec 13, 2013 Bayer Research Magazine, Interview with Doug Ward, Lifecycle Leader, Companion Diagnostics, November 29, 2013 Holiday kindness: TMC gets special gifts, November 25, 2013 more Study of Cross-Contamination of Biopsy Specimens in 69 Anatomic Pathology Laboratories Raises Concerns about Test Quality and Patient Safety, Daily Dark, October 30, 2013 Uncovering Cancer, Digital pathology: science of tomorrow fighting cancer today, ADVANCE, September 3, 2013 Ventana Founder, Tom Grogan, Named AZBio Pioneer by the Arizona Bioindustry Association in Honor of a Lifetime of Biotechnology Achievements August 12, 2013 Personalized Medicine featuring Ventana Medical Systems, Inc., AZ Illustrated Science July 23, 2013 New test for prostate cancer, America Now, May 10, 2013 Dual-Stain Technique for MiRNA, advance for Medical Laboratory Professionals, April 1, 2013 Local Researchers Uncover Genomics Mysteries, AZ Illustrated, February 6, 2013 2012 Ventana Sponsors Congressional Briefing on Patient Safety and Cancer, December 28, 2012 MolecularMD and Ventana Medical Systems, Inc. reach Collaborative Research Agreement, December 7, 2012 Dialogue on Patient Safety and Cancer, November 26, 2012 more Ventana Medical Systems on the leading edge of cancer research, KOLD News 13, November 13, 2012 Mercy North Iowa Launches New Pathology Tracking System, October, 2012 Personalized medicine to save lung cancer patients, KOLD News 13, October 3, 2012 Trying to save 8 Million people, starting with his wife, KOLD News 13, October 1, 2012 Full interview: Trying to save 8 million people, starting with his wife CAP Today: For productivity Gains, histology labs press on, September, 2012 Ventana Strikes Numerous Deals With Pharma Firms This Year, May, 2012 Two for the road with companion diagnostics: Mara Aspinall and Eric Walk share their views in this month’s CAP Today Feature Story, Apr, 2012 CLP Inside Track: Inside Companion Diagnostics, Mar 22, 2012 Ventana President Mara Aspinall: An Interview With “The Pink Sheet” DAILY, Jan 19, 2012 Ventana teams up with Bayer to develop assay, Jan 18, 2012 Ventana’s Growing Companion Dx Focus Mirrors Parent Roche’s Investment in Personalized Rx, Jan 18, 2012 Clovis Oncology Announces Size of Initial hENT1-Low Population in Pivotal LEAP Trial and Provides Financial Guidance for 2012, Jan 9, 2012 Aeterna Zentaris Announces Collaboration with Ventana Medical Systems, Inc. to Develop Companion Diagnostic in Cancer for AEZS-108, Jan 5, 2012 Syndax Pharmaceuticals Signs Agreement with Ventana Medical Systems, Inc. to Develop Companion Diagnostic Test for Entinostat, Jan 5, 2012 2011 New Automated HER2 Test Promises Faster, More Accurate Testing, Nov 29, 2011, Biotechnology Healthcare, 2011 Winter Edition New breast cancer test created and available in Tucson Roche hires diagnostics champion to lead Ventana Medical Systems, August 15, 2011 more Ventana Medical hires new president, August 1, 2011 Roche Acquires mtm laboratories, July 19, 2011 What’s new in slide makers and slide stainers?, July 2011 FDA Approves Ventana Genetic Test For Breast Cancer Treatment, June 14, 2011 Thumbs Up, Hands Off, June 2011 Ventana Medical Systems unveils Virtuoso digital pathology software, April 2011 Media Alerts 2011 August 31, 2011 Innovative Digital Pathology Solutions to be Unveiled at CAP ‘11 — Ventana Medical Systems, Inc. to introduce new technology to revolutionize anatomic pathology laboratories worldwide Inquiries > Media Inquiries > Request a Speaker Services > Roche Medialibrary > Download Corporate Publications RSS-Feeds > Subscribe to Roche News Ventana Medical Systems, Inc. Media Relations Gabrielle Fimbres Manager of External Communications Phone: 520.222.4573 firstname.lastname@example.org For Roche media inquiries, visit Roche media relations.